Clinical Study

Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients

Table 4

Results of the multivariate Cox hazard model for disease-free survival in stage II colorectal patients ().

Hazard ratio95% CI value

CEA5.10.9–30.60.07
CRP8.21.1–61.20.04
IL-60.10.01–0.60.01
Obstruction2.00.4–10.20.4
T46.71.4–31.60.02

OR: odds ratio; CI: confidence interval; CEA: carcinoembryonic antigen; CRP: C-reactive protein; IL-6: interleukin-6.